EP and Fetal Arrhythmias Flashcards
Most common pediatric dysrhythmia
Paroxysmal SVT
Antibody associated with congenital lupus
- Anti Ro/SSA
- Anti La/SSB
Location of bundle of His in truncus arteriosus
Left aspect of the posterior/inferior rim of the VSD
Location of conduction fibers in ccTGA
Anterior superior rim
Most common fetal presentation of long QT
Sinus bradycardia with bursts of SVT
Incidence of fetal arrhythmias
1-3% but only 10% of these cause morbidity
Definition of fetal bradycardia
- Rate < 110/min
- If abnormal AV conduction have 50% risk of CHD
Definition of fetal tachycardia
- Rate > 180/min
- Baseline risk of CHD (1%)
Follow-up needed for fetal PACs
- If frequent (every 3-5 beats) then weekly OB assessment
- If infrequent, nothing special
Things to exclude for fetal PVCs
Myocarditis, cardiac tumors, maternal drug exposures
What types of CHD are at increased risk with fetal tachycardia
- Ebsteins
- Complete AV canal
- HLHS
Fetal echo signs of tachyarrythmias
- Early: atrial enlargement or AVV regurgitation
- Late: ventricular dysfunction, effusion, hydrops, cardiomegayl
- TACHY PLUS HYDROS = 50% mortality
1st and 2nd most common fetal tachyarrhythmias
- AV reciprocating SVT with accessory pathway (70-90%)
- Atrial flutter (10-30%)
1st line drug for fetal SVT
Digoxin - 50% termination
Oral load and higher doses
Direct IM is an option if hydrops
Check maternal levels and ECGs
2nd line drugs for fetal tachyarrhythmias
- Sotalol: B blocker and K channel - daily ECG, some say better for A flutter
- Flecainide - Na channel - daily ECG, some say better for SVT and not flutter
Things to rule out for fetal VT and treatment of fetal VT
- Tumors, myocarditis, channelopathies, AV block
- Tx: maternal IV mag or lido, oral propanolol or mexilitene
Percentage of congenital complete AV block that have CHD vs immune mediated
- 50-55% have complex CHD (heterotaxy or L looping)
- 40% are immune mediated with anti-Ro/SSA or anti-La/SSB antibodies
Percent risk of CCHB with known maternal antibodies
- 3-5%
- If prior then risk increases to 11-20%
Risks for death with CCHB
Structural CHD
HR < 55 at presentation
Hydrops
Decreased function
Difference between ORT vs ART
- ORT has narrow QRS
- ART has wide QRS with preexcitation
- Both are accessory pathway mediated reentrant tachycardias with HR 200-250
Accessory pathway tachycardia associated with which CHD
- Ebsteins
- LTGA
Definition of PJRT
- Permanent junctional reciprocating tachycardia
- No preexcitation at baseline
- Long VA during tachycardia, slower rates during SVT
Acute treatment of SVT
- B block or CCB If normal EF and no preexcitation at baseline
- Dig if no preescitation at baseline
- DCCV
- Amio if decreased EFC
Chronic treatment of SVT
- If preexcitation: B blockers, Class Ia/Ic/III
- No digoxin or verapamil due to risk for rapid anterograde conduction and VF if there is preexcitation
- If no preexcitation can use digoxin, B blockers, Class Ia/Ic/III/IV